how would someone under such a system decide to take a drug or not? what information would they have?
Also: Postmarketing surveillance data, peer-reviewed journals, mechanistic analysis, etc. There are lots of ways to decide which drugs might be of benefit. Leaving the decision to the FDA has, to this point, done far more harm than good.
Raise your hand if you think that would be better.